Faculty home

Pharmacy and Pharmaceutical Sciences

Only through community and collaboration can we achieve the best possible results. Together we aim to shift gears and change old ways of thinking. And we need people like you – your skills, your perspectives, your passion.

Stay up-to-date with the latest news from inside the world of Pharmacy and Pharmaceutical Sciences.

MIPS Director awarded APSA Medal

Professor Chris Porter, Director of the Monash Institute of Pharmaceutical Sciences (“MIPS”), has been named the 2017 Australasian Pharmaceutical Science Association (“APSA”) medallist.

MIPS researcher wins prestigious Heart Foundation Award

Dr Lauren May, of the Drug Discovery Biology research theme at the Monash Institute of Pharmaceutical Science, has received a Heart Foundation Future Leaders Fellowship and Paul Korner Innovation Award.

Research to tackle mental illness bolstered with $10 million

Research focused on improving mental health treatment and care has been recognised with major funding grants announced by the Federal Government today.

More than $53 million in funding across 47 mental health projects was announced by the National Health and Medical Research Council (NHMRC) this morning.

Faculty hosts 12th International Conference on Cerebral Vascular Biology

28 November 2017

The Faculty of Pharmacy and Pharmaceutical Sciences is delighted to today welcome 220 delegates from 25 countries around the globe for the 12th International Conference on Cerebral Vascular Biology (CVB 2017).

This is the first time in the 25 years of the conference that this number of scientists and clinicians will congregate in the Southern Hemisphere.

Johnson George

CMUS researchers receive GRAND to tackle nicotine dependence

A group of researchers, led by Dr Johnson George from the Centre for Medicine Use and Safety (CMUS), has received a Global Research Awards for Nicotine Dependence (GRAND) worth USD $200 000. 

The research project entitled ‘Varenicline And Nicotine replacement therapy for Smokers admitted to Hospitals (VANISH)’ was one of six proposals to receive an award. The project will involve a randomised, placebo-controlled trial in five Australian public hospitals comparing the efficacy of varenicline in combination with Nicotine Replacement Therapy (NRT) lozenge and Quitline referral versus varenicline with NRT placebo and Quitline referral.

Dr George’s group includes Professor Michael Abramson (School of Public Health, Monash University), Professor Billie Bonevski (University of Newcastle), Professor Michael Dooley (CMUS and Alfred Health), Professor Brian Smith (Queen Elizabeth Hospital, Adelaide) and Dr Ashley Webb (Peninsula Health).

View more articles